Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Dec 16, 2008

Premium
CombiMatrix Molecular Diagnostics this week launched its ProScan test for prostate cancer.
 
The array comparative genomic hybridization-based ProScan test comprises probes for specific genomic loci of which copy number gains and losses have been shown to correlate with risk of recurrence and metastasis in patients post-prostatectomy, CMDX said.
 
The additional probes are an enhancement of the CMDX solid tumor array platform design which enables whole-genome tumor profiling, or genomic grading, while also providing information about the copy-number status of specific disease-associated loci, the firm said.
 
ProScan is available through CMDX’s CLIA-compliant lab in Irvine, Calif.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.